New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort

OBJECTIVE: To assess the incidence of new adverse coronary events (NACE) following transcatheter aortic valve replacement (TAVR) and valve-in-valve TAVR (ViV-TAVR). BACKGROUND: ViV-TAVR is an accepted treatment for degenerative prostheses among patients with high surgical-risk. TAVR studies have sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Koren, Ofir, Patel, Vivek, Naami, Robert, Naami, Edmund, Nagasaka, Takashi, Shechter, Alon, Natanzon, Sharon Shalom, Kohan, Siamak, Allison, Zev, Lerner, Addee, Cheng, Daniel Eugene, Chakravarty, Tarun, Nakamura, Mamoo, Cheng, Wen, Jilaihawi, Hasan, Makkar, Raj R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532571/
https://www.ncbi.nlm.nih.gov/pubmed/36211543
http://dx.doi.org/10.3389/fcvm.2022.1004103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532571/
https://www.ncbi.nlm.nih.gov/pubmed/36211543
http://dx.doi.org/10.3389/fcvm.2022.1004103

Ejemplares similares